Literature DB >> 24005418

The appearance of Tregs in cancer nest is a promising independent risk factor in colon cancer.

Wei Xu1, Hao Liu, Jun Song, Hai-Xiao Fu, Lei Qiu, Bao-Fu Zhang, Hui-Zhong Li, Jin Bai, Jun-Nian Zheng.   

Abstract

PURPOSE: To investigate the prognostic value of tumor-infiltrating regulatory T cells (Tregs) in the distribution of cancer nest, cancer stroma and normal mucosa and FOXP3-positive cancer cells in colon cancer patients after resection.
METHODS: Paraffin blocks of operation resection of primary adenocarcinoma of colon were obtained from ninety patients. The distribution of tumor-infiltrating Tregs was detected by tissue microarray and immunohistochemistry staining technique to evaluate the prognostic effects by Kaplan-Meier and Cox regression analysis using median values as cutoff.
RESULTS: The intratumoral Tregs counts were significantly higher than that in corresponding normal mucosa tissues (P < 0.001); the Tregs counts in cancer nest were significantly lower than that in corresponding cancer stroma tissues (P < 0.001); the increased intratumoral Tregs counts were associated with favorable prognosis (P < 0.05); the presence of Tregs in cancer nest was associated with unfavorable prognosis and was an independent prognostic factor for overall survival (P < 0.05). The appearance of FOXP3-positive cancer cells was associated with worse prognosis (P < 0.05). In addition, the frequency of the presence of FOXP3-positive cancer cells was higher in patients with lymphatic invasion (P < 0.001) and lower in patients with early TNM stage (P < 0.01).
CONCLUSIONS: The higher tumor-infiltrating Tregs counts are closely associated with the improved prognostic effects of colon carcinoma. Tregs play different roles in cancer nest and cancer stroma. And the appearance of Tregs in cancer nest is a promising independent risk factor for overall survival in colon carcinoma. FOXP3-positive cancer cells may also be a risk factor for overall survival in colon carcinoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24005418     DOI: 10.1007/s00432-013-1500-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  27 in total

1.  Effector memory T cells, early metastasis, and survival in colorectal cancer.

Authors:  Franck Pagès; Anne Berger; Matthieu Camus; Fatima Sanchez-Cabo; Anne Costes; Robert Molidor; Bernhard Mlecnik; Amos Kirilovsky; Malin Nilsson; Diane Damotte; Tchao Meatchi; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Jérôme Galon
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

Authors:  Nobuyoshi Hiraoka; Kaoru Onozato; Tomoo Kosuge; Setsuo Hirohashi
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

3.  Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.

Authors:  Rebecca P Petersen; Michael J Campa; Justin Sperlazza; Debbi Conlon; Mary-Beth Joshi; David H Harpole; Edward F Patz
Journal:  Cancer       Date:  2006-12-15       Impact factor: 6.860

4.  Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

Authors:  Qiang Gao; Shuang-Jian Qiu; Jia Fan; Jian Zhou; Xiao-Ying Wang; Yong-Sheng Xiao; Yang Xu; Yi-Wei Li; Zhao-You Tang
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

5.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

6.  Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer.

Authors:  Sebastian Hinz; Laia Pagerols-Raluy; Hans-Heinrich Oberg; Ole Ammerpohl; Sandra Grüssel; Bence Sipos; Robert Grützmann; Christian Pilarsky; Hendrik Ungefroren; Hans-Detlev Saeger; Günter Klöppel; Dieter Kabelitz; Holger Kalthoff
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

7.  Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer.

Authors:  Giuseppe Perrone; Pier Adelchi Ruffini; Vincenzo Catalano; Cathie Spino; Daniele Santini; Pietro Muretto; Chiara Spoto; Costantino Zingaretti; Valerio Sisti; Paolo Alessandroni; Paolo Giordani; Andrea Cicetti; Silvia D'Emidio; Sergio Morini; Annamaria Ruzzo; Mauro Magnani; Giuseppe Tonini; Carla Rabitti; Francesco Graziano
Journal:  Eur J Cancer       Date:  2008-07-09       Impact factor: 9.162

8.  The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma.

Authors:  Jin F Li; Yi W Chu; Guo M Wang; Tong Y Zhu; Rui M Rong; Jun Hou; Ming Xu
Journal:  BJU Int       Date:  2008-11-19       Impact factor: 5.588

9.  FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.

Authors:  Tao Zuo; Lizhong Wang; Carl Morrison; Xing Chang; Huiming Zhang; Weiquan Li; Yan Liu; Yin Wang; Xingluo Liu; Michael W Y Chan; Jin-Qing Liu; Richard Love; Chang-Gong Liu; Virginia Godfrey; Rulong Shen; Tim H-M Huang; Tianyu Yang; Bae Keun Park; Cun-Yu Wang; Pan Zheng; Yang Liu
Journal:  Cell       Date:  2007-06-14       Impact factor: 41.582

10.  Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer.

Authors:  Mia Kim; Tanja Grimmig; Martin Grimm; Maria Lazariotou; Eva Meier; Andreas Rosenwald; Igor Tsaur; Roman Blaheta; Uwe Heemann; Christoph-Thomas Germer; Ana Maria Waaga-Gasser; Martin Gasser
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more
  10 in total

1.  Foxp3 expression in CD4+CD25+Foxp3+ regulatory T cells promotes development of colorectal cancer by inhibiting tumor immunity.

Authors:  Xiao-Wen Zhu; Hai-Zhen Zhu; You-Qing Zhu; Mao-Hui Feng; Jian Qi; Zhi-Fen Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

2.  Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.

Authors:  Younghoon Kim; Jeong Mo Bae; Gang Li; Nam Yun Cho; Gyeong Hoon Kang
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

3.  The Clinicopathological and Prognostic Implications of FoxP3+ Regulatory T Cells in Patients with Colorectal Cancer: A Meta-Analysis.

Authors:  Peipei Xu; Wei Fan; Zheng Zhang; June Wang; Ping Wang; Yirong Li; Mingxia Yu
Journal:  Front Physiol       Date:  2017-11-21       Impact factor: 4.566

4.  Tumor-infiltrating FoxP3+ Tregs predict favorable outcome in colorectal cancer patients: A meta-analysis.

Authors:  Guoming Hu; Zhi'an Li; Shimin Wang
Journal:  Oncotarget       Date:  2017-06-07

5.  Reduced GRAMD1C expression correlates to poor prognosis and immune infiltrates in kidney renal clear cell carcinoma.

Authors:  Haiyan Hao; Ziheng Wang; Shiqi Ren; Hanyu Shen; Hua Xian; Wenliang Ge; Wei Wang
Journal:  PeerJ       Date:  2019-12-20       Impact factor: 2.984

Review 6.  The Role of Tumor Microenvironment and Immune Response in Colorectal Cancer Development and Prognosis.

Authors:  Maria Wozniakova; Jozef Skarda; Milan Raska
Journal:  Pathol Oncol Res       Date:  2022-07-21       Impact factor: 2.874

7.  FOXP3 and CEACAM6 expression and T cell infiltration in the occurrence and development of colon cancer.

Authors:  Yingying Liu; Tingting Xia; Chunhui Jin; Dongmei Gu; Jie Yu; Weiqiang Shi; K E Zhang; Liping Zhang; Jianxin Ye; Ling Li
Journal:  Oncol Lett       Date:  2016-04-14       Impact factor: 2.967

8.  A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy.

Authors:  Jingjing Duan; Yongwei Xie; Lijuan Qu; Lingxiong Wang; Shunkai Zhou; Yu Wang; Zhongyi Fan; Shengsheng Yang; Shunchang Jiao
Journal:  J Immunother Cancer       Date:  2018-10-03       Impact factor: 13.751

9.  Transforming growth factor-β and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma.

Authors:  Yang An; Song Gao; Wen-Chao Zhao; Bao-An Qiu; Nian-Xin Xia; Peng-Jun Zhang; Zhen-Ping Fan
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

Review 10.  Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf.

Authors:  Massimo Claudio Fantini; Agnese Favale; Sara Onali; Federica Facciotti
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.